Evidence map›Paper›PMID 30994044›Full record

ArticleJournal of the American Heart Association2019

Chromatin Conformation Links Putative Enhancers in Intracranial Aneurysm-Associated Regions to Potential Candidate Genes.

Melanie D Laarman, Geert Geeven, Phil Barnett, Netherlands Brain Bank, Gabriël J E Rinkel, Wouter de Laat, Ynte M Ruigrok, Jeroen Bakkers

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Dissecting the Genetic Architecture of Intracranial Aneurysms.Circulation. Genomic and precision medicine · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Melanie D Laarman1 Department of Neurology and Neurosurgery Brain Center Rudolf Magnus University Medical Center, Utrecht the Netherlands.
Geert Geeven2 Hubrecht Institute (Royal Netherlands Academy of Arts and Sciences (KNAW)) University Medical Center, Utrecht the Netherlands.
Phil Barnett4 Department of Medical Biology Academic Medical Center University of Amsterdam the Netherlands.
Netherlands Brain Bank5 Netherlands Institute for Neuroscience Amsterdam the Netherlands.
Gabriël J E Rinkel1 Department of Neurology and Neurosurgery Brain Center Rudolf Magnus University Medical Center, Utrecht the Netherlands.
Wouter de Laat2 Hubrecht Institute (Royal Netherlands Academy of Arts and Sciences (KNAW)) University Medical Center, Utrecht the Netherlands.
Ynte M Ruigrok1 Department of Neurology and Neurosurgery Brain Center Rudolf Magnus University Medical Center, Utrecht the Netherlands.
Jeroen Bakkers2 Hubrecht Institute (Royal Netherlands Academy of Arts and Sciences (KNAW)) University Medical Center, Utrecht the Netherlands.
Royal Netherlands Academy of Arts and Sciences · NLAmsterdam UMC Location University of Amsterdam · NLNetherlands Institute for Neuroscience · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background We previously showed that intracranial aneurysm ( IA )-associated single-nucleotide polymorphisms are enriched in promoters and putative enhancers identified in the human circle of Willis, on which IA s develop, suggesting a role for promoters and enhancers in IAs . We further investigated the role of putative enhancers in the pathogenesis of IA by identifying their potential target genes and validating their regulatory activity. Methods and Results Using our previously published circle of Willis chromatin immunoprecipitation and sequencing data, we selected 34 putative enhancers in IA -associated regions from genome-wide association studies. We then used a chromatin conformation capture technique to prioritize target genes and found that 15 putative enhancers interact with the promoters of 6 target genes: SOX 17, CDKN 2B, MTAP , CNNM 2, RPEL 1, and GATA 6. Subsequently, we assessed the activity of these putative enhancers in vivo in zebrafish embryos and confirmed activity for 8 putative enhancers. Last, we found that all 6 target genes are expressed in the circle of Willis, on the basis of RNA sequencing data and in situ hybridization. Furthermore, in situ hybridization showed that these genes are expressed in multiple cell types in the circle of Willis. Conclusions In 4 of 6 IA -associated genome-wide association study regions, we identified 8 putative enhancers that are active in vivo and interact with 6 nearby genes, suggesting that these genes are regulated by the identified putative enhancers. These genes, SOX 17, CDKN 2B, MTAP , CNNM 2, RPEL 1, and GATA 6, are therefore potential candidate genes involved in IA pathogenesis and should be studied using animal models in the future.

Indexed as

Aged, 80 and overCation Transport ProteinsChromatinChromatin ImmunoprecipitationChromatin Immunoprecipitation SequencingCircle of WillisCyclin-Dependent Kinase Inhibitor p15Enhancer Elements, GeneticFemaleGATA6 Transcription FactorHumansIntracranial AneurysmMicrotubule-Associated ProteinsMiddle AgedMolecular ConformationPolymorphism, Single NucleotideCation Transport ProteinsCDKN2B protein, humanChromatinCNNM2 protein, humanCyclin-Dependent Kinase Inhibitor p15GATA6 protein, humanGATA6 Transcription FactorMicrotubule-Associated ProteinsSOX17 protein, humanSOXF Transcription Factorscircle of Willisgene regulationintracranial aneurysmsingle‐nucleotide polymorphismzebrafish

Identifiers

PMID30994044
PMCPMC6512097
OpenAlexW2940084495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.